Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China · Delayed Price · Currency is CNY 5.78
+0.05 (0.87%)
At close: Sep 30, 2026
SHA:688373 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 282.3 | 316.1 | 386.26 | 166.31 | 151.09 | 145.52 |
Trading Asset Securities | 111.27 | 135.54 | 207.36 | 786.98 | 1,119 | 326.36 |
Cash & Short-Term Investments | 393.58 | 451.64 | 593.62 | 953.3 | 1,270 | 471.88 |
Cash Growth | -24.64% | -23.92% | -37.73% | -24.95% | 169.17% | -25.92% |
Accounts Receivable | 40.97 | 37.96 | 31.88 | 21.98 | 11.1 | 1.42 |
Other Receivables | 19.93 | 20.52 | 21.02 | 0.19 | 0.34 | 0 |
Receivables | 60.9 | 58.47 | 52.9 | 22.17 | 11.44 | 1.42 |
Inventory | 46.04 | 50.25 | 52.94 | 37.52 | 21.89 | 11.01 |
Other Current Assets | 48.97 | 62.09 | 49.21 | 41.27 | 67.01 | 25.29 |
Total Current Assets | 549.48 | 622.46 | 748.66 | 1,054 | 1,371 | 509.59 |
Property, Plant & Equipment | 57.94 | 61.73 | 75.8 | 86.21 | 97.46 | 122.8 |
Other Intangible Assets | 0.65 | 0.95 | 1.68 | 1.93 | 2.19 | 0.84 |
Long-Term Deferred Charges | 14.51 | 16.04 | 19.1 | 21.75 | 22.68 | 1.83 |
Other Long-Term Assets | 3.91 | 3.91 | 3.89 | 4.42 | 4.54 | 13.48 |
Total Assets | 627.65 | 705.09 | 849.13 | 1,169 | 1,497 | 648.54 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 8.88 | 16.57 | 26.21 | 11.13 | 10.85 | 1.91 |
Accrued Expenses | 84.84 | 96.51 | 78.63 | 94.51 | 37.41 | 29.45 |
Short-Term Debt | 25.07 | 25.02 | 5 | - | 48.75 | 50.08 |
Current Portion of Long-Term Debt | 112.94 | 68.42 | 89.23 | 14.15 | 10.1 | - |
Current Portion of Leases | 12.38 | 12.77 | 11.51 | 10.38 | 6.47 | 11.04 |
Current Income Taxes Payable | 1.76 | 0.2 | - | 4.41 | - | - |
Current Unearned Revenue | 0.47 | 0.47 | - | 0.13 | - | - |
Other Current Liabilities | 6.3 | 4.42 | 1.71 | 1.93 | 1.52 | 1.71 |
Total Current Liabilities | 252.63 | 224.38 | 212.3 | 136.65 | 115.11 | 94.19 |
Long-Term Debt | 146.84 | 213.04 | 122.94 | 114.96 | 70 | - |
Long-Term Leases | 63.48 | 60.38 | 73.18 | 81.7 | 94.89 | 99.87 |
Long-Term Unearned Revenue | 1.75 | 1.75 | 1.75 | 1.25 | 3.1 | 16.1 |
Total Liabilities | 464.7 | 499.55 | 410.16 | 334.56 | 283.1 | 210.17 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 656.23 | 656.23 | 655.61 | 655.21 | 655.21 | 525.21 |
Additional Paid-In Capital | 1,588 | 1,588 | 1,571 | 1,532 | 1,495 | 636.77 |
Retained Earnings | -2,084 | -2,046 | -1,805 | -1,364 | -942.85 | -722.55 |
Comprehensive Income & Other | 2.24 | 7.69 | 17.08 | 10.91 | 7.19 | -1.06 |
Shareholders' Equity | 162.95 | 205.54 | 438.96 | 834 | 1,214 | 438.37 |
Total Liabilities & Equity | 627.65 | 705.09 | 849.13 | 1,169 | 1,497 | 648.54 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 360.7 | 379.62 | 301.86 | 221.19 | 230.21 | 160.99 |
Net Cash (Debt) | 32.88 | 72.02 | 291.76 | 732.11 | 1,040 | 310.88 |
Net Cash Growth | -80.32% | -75.32% | -60.15% | -29.60% | 234.52% | -50.69% |
Net Cash Per Share | 0.05 | 0.11 | 0.44 | 1.12 | 1.79 | 0.59 |
Filing Date Shares Outstanding | 656.23 | 655.61 | 655.61 | 655.21 | 655.21 | 525.21 |
Total Common Shares Outstanding | 656.23 | 655.61 | 655.61 | 655.21 | 655.21 | 525.21 |
Working Capital | 296.85 | 398.08 | 536.37 | 917.61 | 1,255 | 415.39 |
Book Value Per Share | 0.25 | 0.31 | 0.67 | 1.27 | 1.85 | 0.83 |
Tangible Book Value | 162.29 | 204.59 | 437.28 | 832.07 | 1,212 | 437.53 |
Tangible Book Value Per Share | 0.25 | 0.31 | 0.67 | 1.27 | 1.85 | 0.83 |
Machinery | 14.88 | 14.8 | 14.41 | 14.18 | 11.75 | 6.01 |
Construction In Progress | - | - | - | - | - | 15.65 |